14-day Premium Trial Subscription Try For FreeTry Free
RSI low/high Values: [ 25 - 75 ]
* StockInvest.us uses dynamically calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.
AI Analysis of RAC.AX
Powered by GPT-4
Upgraded!
Stock Analysis
Risk Assessment
Trading Strategy

Race Oncology Limited stock price ended at $1.55 on Friday, after losing 0.96%.
(Updated on May 17, 2024)

Buy candidate since May 16, 2024 Loss -0.96% PDF

The Race Oncology Limited stock price fell by -0.96% on the last day (Friday, 17th May 2024) from $1.57 to $1.55. It has now fallen 3 days in a row. During the last trading day the stock fluctuated 5.65% from a day low at $1.51 to a day high of $1.59. The price has risen in 6 of the last 10 days and is up by 27.05% over the past 2 weeks. Volume has increased on the last day by 62 thousand shares but on falling prices. This may be an early warning and the risk will be increased slightly over the next couple of days. In total, 122 thousand shares were bought and sold for approximately $188.56 thousand.

The stock lies in the middle of a very wide and strong rising trend in the short term and a further rise within the trend is signaled. Given the current short-term trend, the stock is expected to rise 41.80% during the next 3 months and, with a 90% probability hold a price between $1.82 and $2.99 at the end of this 3-month period.

Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.

RAC.AX Signals & Forecast

The Race Oncology Limited stock holds buy signals from both short and long-term Moving Averages giving a positive forecast for the stock. Also, there is a general buy signal from the relation between the two signals where the short-term average is above the long-term average. On corrections down, there will be some support from the lines at $1.52 and $1.42. A breakdown below any of these levels will issue sell signals. Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Some negative signals were issued as well, and these may have some influence on the near short-term development. A sell signal was issued from a pivot top point on Monday, March 18, 2024, and so far it has fallen -8.28%. Further fall is indicated until a new bottom pivot has been found. Race Oncology Limited gained volume on the last day, but on falling prices. In technical terms, this is called divergence and may be an early warning. In some cases, increasing volume on falling prices may be considered positive, but that is mainly in typical "sell-offs".

Support, Risk & Stop-loss for Race Oncology Limited stock

Race Oncology Limited finds support from accumulated volume at $1.52 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock may move much during the day (volatility) and with a large prediction interval from the Bollinger Band this stock is considered to be "high risk". During the last day, the stock moved $0.0850 between high and low, or 5.65%. For the last week, the stock has had daily average volatility of 7.41%.

Our recommended stop-loss: $1.48 (-4.62%) (This stock has high daily movements and this gives high risk. There is a sell signal from a pivot top found 41 days ago.)

Trading Expectations (RAC.AX) For The Upcoming Trading Day Of Monday 20th

For the upcoming trading day on Monday, 20th we expect Race Oncology Limited to open at $1.55, and during the day (based on 14 day Average True Range), to move between $1.45 and $1.65, which gives a possible trading interval of +/-$0.0962 (+/-6.21%) up or down from last closing price. If Race Oncology Limited takes out the full calculated possible swing range there will be an estimated 12.42% move between the lowest and the highest trading price during the day.

Since the stock is closer to the support from accumulated volume at $1.52 (1.94%) than the resistance at $1.63 (4.84%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..

Is Race Oncology Limited stock A Buy?

Several short-term signals, along with a general good trend, are positive and we conclude that the current level may hold a buying opportunity as there is a fair chance for Race Oncology Limited stock to perform well in the short-term.

Current score: 3.650 Buy Candidate Unchanged

Predicted Opening Price for Race Oncology Limited of Monday, May 20, 2024

Fair opening price May 20, 2024 Current price
$1.55 ( 0.108%) $1.55

The predicted opening price is based on yesterday's movements between high, low, and closing price.

Trading levels for RAC.AX

Fibonacci Support & Resistance Levels

Level Price
Resistance R3 1.63 5.38 %
R2 1.60 3.28 %
R1 1.58 1.99 %
Current price: 1.55
Support S1 1.52 -2.20 %
S2 1.50 -3.50 %
S3 1.46 -5.59 %

Accumulated Volume Support & Resistance Levels

Level Price
Resistance R3 1.69 9.03 %
R2 1.65 6.45 %
R1 1.63 4.84 %
Current price 1.55
Support S1 1.52 -1.94%
S2 1.33 -14.52%
S3 1.22 -21.29%

FAQ

What is the symbol for Race Oncology Limited Stock and on which exchange is it traded?
The symbol for Race Oncology Limited is RAC.AX and it is traded on the ASX (Australian Securities Exchange).

Should I buy or sell Race Oncology Limited Stock?
Several short-term signals, along with a general good trend, are positive and we conclude that the current level may hold a buying opportunity as there is a fair chance for Race Oncology Limited stock to perform well in the short-term.

How to buy Race Oncology Limited Stock?
Race Oncology Limited Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Race Oncology Limited Stock.

What's the current price of Race Oncology Limited Stock?
As of the end of day on the May 17, 2024, the price of an Race Oncology Limited (RAC.AX) share was $1.55.

What is the 52-week high and low for Race Oncology Limited Stock?
The 52-week high for Race Oncology Limited Stock is $1.81 and the 52-week low is $0.640.

What is the market capitalization of Race Oncology Limited Stock?
As of the May 17, 2024, the market capitalization of Race Oncology Limited is 257.897M.

When is the next earnings date for Race Oncology Limited?
The upcoming earnings date for Race Oncology Limited is Jul 29, 2024.
Click to get the best stock tips daily for free!

About Race Oncology Limited

Race Oncology Limited Race Oncology Limited operates as a precision oncology company in Australia. The company is developing Zantrene, a potent small molecule inhibitor of the fatso/fat mass and obesity associated protein for treating for melanoma and clear cell renal cell carcinoma, as well as acute myeloid leukaemia, breast, and ovarian cancers, which is in Phase II/III clinical trial. It has a preclinical research program with the University of Newcastle for invest... RAC.AX Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT